ACOG
Price
$8.58
Change
+$0.68 (+8.61%)
Updated
Jul 27 closing price
Capitalization
186.82M
Intraday BUY SELL Signals
NGNE
Price
$34.62
Change
-$0.28 (-0.80%)
Updated
Jul 27 closing price
Capitalization
690.28M
10 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACOG vs NGNE

ACOG vs NGNE Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ACOG vs. NGNE commentary
Jul 28, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACOG is a Buy and NGNE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2026
Stock price -- (ACOG: $8.58 vs. NGNE: $34.62)
Brand notoriety: ACOG and NGNE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACOG: 125% vs. NGNE: 76%
Market capitalization -- ACOG: $186.82M vs. NGNE: $690.28M
ACOG [@Biotechnology] is valued at $186.82M. NGNE’s [@Biotechnology] market capitalization is $690.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.57B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACOG’s FA Score shows that 1 FA rating(s) are green whileNGNE’s FA Score has 0 green FA rating(s).

  • ACOG’s FA Score: 1 green, 4 red.
  • NGNE’s FA Score: 0 green, 5 red.
According to our system of comparison, ACOG is a better buy in the long-term than NGNE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACOG’s TA Score shows that 5 TA indicator(s) are bullish while NGNE’s TA Score has 3 bullish TA indicator(s).

  • ACOG’s TA Score: 5 bullish, 5 bearish.
  • NGNE’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ACOG is a better buy in the short-term than NGNE.

Price Growth

ACOG (@Biotechnology) experienced а +2.88% price change this week, while NGNE (@Biotechnology) price change was -7.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.94%. For the same industry, the average monthly price growth was -4.26%, and the average quarterly price growth was +1936.60%.

Reported Earning Dates

NGNE is expected to report earnings on Aug 07, 2026.

Industries' Descriptions

@Biotechnology (-1.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NGNE($690M) has a higher market cap than ACOG($187M). NGNE YTD gains are higher at: 68.058 vs. ACOG (32.000). ACOG has higher annual earnings (EBITDA): -27.26M vs. NGNE (-95.45M). NGNE has more cash in the bank: 243M vs. ACOG (54.2M). ACOG has less debt than NGNE: ACOG (2.21M) vs NGNE (9.54M). ACOG has higher revenues than NGNE: ACOG (10.8M) vs NGNE (0).
ACOGNGNEACOG / NGNE
Capitalization187M690M27%
EBITDA-27.26M-95.45M29%
Gain YTD32.00068.05847%
P/E RatioN/AN/A-
Revenue10.8M0-
Total Cash54.2M243M22%
Total Debt2.21M9.54M23%
FUNDAMENTALS RATINGS
NGNE: Fundamental Ratings
NGNE
OUTLOOK RATING
1..100
90
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACOGNGNE
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 8 days ago
86%
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 1 day ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ACOG
Daily Signal:
Gain/Loss:
NGNE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGAIX55.140.31
+0.57%
Baron Global Opportunity Institutional
TLVIX37.410.05
+0.13%
Thrivent Large Cap Value S
LBDRX23.98N/A
N/A
BrandywineGLOBAL Div US Large Value R
CDDRX41.32N/A
N/A
Columbia Dividend Income Inst2
PSVDX23.16N/A
N/A
PGIM Quant Solutions Small-Cap Val R2

ACOG and

Correlation & Price change

A.I.dvisor tells us that ACOG and ORIC have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACOG and ORIC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACOG
1D Price
Change %
ACOG100%
+8.61%
ORIC - ACOG
29%
Poorly correlated
-0.66%
WHWK - ACOG
29%
Poorly correlated
-0.27%
ACAD - ACOG
29%
Poorly correlated
+2.21%
MGTX - ACOG
28%
Poorly correlated
+4.50%
NGNE - ACOG
28%
Poorly correlated
-0.80%
More

NGNE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NGNE has been loosely correlated with BRNS. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if NGNE jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NGNE
1D Price
Change %
NGNE100%
-0.80%
BRNS - NGNE
51%
Loosely correlated
-0.20%
RNAZ - NGNE
48%
Loosely correlated
-8.09%
RCKT - NGNE
46%
Loosely correlated
+1.88%
BCYC - NGNE
45%
Loosely correlated
+2.07%
TSHA - NGNE
45%
Loosely correlated
+0.36%
More